Robert Levak
Direktor/Vorstandsmitglied bei Voxcell Bioinnovation, Inc.
Profil
Robert Levak is currently a Director at Phoenix Molecular Designs Ltd.
and Voxcell Bioinnovation, Inc. He completed his undergraduate degree at the University of British Columbia and his MBA at Kellogg School of Management.
Aktive Positionen von Robert Levak
Unternehmen | Position | Beginn |
---|---|---|
Voxcell Bioinnovation, Inc.
Voxcell Bioinnovation, Inc. Industrial MachineryProducer Manufacturing Voxcell Bioinnovation, Inc. is a Canadian company that creates solutions for the drug development industry and Oncology research. The company is based in Victoria, Canada. The company offers a range of products including Novel Bioinks, Truly Biomimetic Tissue Models for in vitro drug testing, and a unique super high resolution 3D Bioprinter. The company was founded by Karolina Valente and she has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.06.2022 |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 01.03.2021 |
Ausbildung von Robert Levak
University of British Columbia | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Voxcell Bioinnovation, Inc.
Voxcell Bioinnovation, Inc. Industrial MachineryProducer Manufacturing Voxcell Bioinnovation, Inc. is a Canadian company that creates solutions for the drug development industry and Oncology research. The company is based in Victoria, Canada. The company offers a range of products including Novel Bioinks, Truly Biomimetic Tissue Models for in vitro drug testing, and a unique super high resolution 3D Bioprinter. The company was founded by Karolina Valente and she has been the CEO since incorporation. | Producer Manufacturing |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Commercial Services |